Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CPPED1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TSFM - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SIAE - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PPID - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IPO5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PTPRF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SSX2IP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SRPRB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAVS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DIAPH3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
REEP5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CD44 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
XPOT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PDLIM5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FBXW2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMX4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STX2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC46A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
R3HDM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPP14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on